Francis C. C. Chow

Advancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor Agonist, Versus Thrice-Daily Prandial Insulin Lispro

Julio Rosenstock, Vivian Fonseca, Jorge Luiz Gross et al. · Diabetes Care · 2014 · 202 citations

Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy

L Adhikary, Francis C. C. Chow, David J. Nikolic‐Paterson et al. · Diabetologia · 2004 · 193 citations · Full text

Glomerulonephritis, Urology, Signal Transduction +13

Premature Mortality and Comorbidities in Young-onset Diabetes: A 7-Year Prospective Analysis

Juliana C.N. Chan, Eric S. H. Lau, Andrea O. Y. Luk et al. · The American Journal of Medicine · 2014 · 156 citations

Metabolic Syndrome, Diabetes Management, Diabetes Epidemiology +12

Risk association of HbA_1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry

Andrea O. Y. Luk, Ronald C.W., Eric S. H. Lau et al. · Diabetes/Metabolism Research and Reviews · 2013 · 142 citations

Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: A 26-week, randomised, treat-to-target trial

Shizuka Kaneko, Francis C. C. Chow, Dong Seop Choi et al. · Diabetes Research and Clinical Practice · 2014 · 80 citations · Full text